ID
26889
Beskrivning
Study ID: 101468/199 Clinical Study ID: 101468/199 Study Title: An open label study conducted in healthy volunteers to characterize the pharmacokinetics of a new unmarketed formulation of ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome Documentation part (Visit Description): Study Conclusion
Nyckelord
Versioner (1)
- 2017-10-27 2017-10-27 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
27 oktober 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Pharmacokinetics of a new unmarketed formulation of ropinirole Study Conclusion 101468/199
Study Conclusion
- StudyEvent: ODM
Beskrivning
Investigator Comment Log
Alias
- UMLS CUI-1
- C0008961
- UMLS CUI-2
- C0947611
Similar models
Study Conclusion
- StudyEvent: ODM
C0008972 (UMLS CUI-2)
C0244821 (UMLS CUI-3)
C2349954 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,2])
C0947611 (UMLS CUI-2)
C0008961 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])